Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
10/2004
10/07/2004US20040198756 Piperidien compound; bactericide
10/07/2004US20040198740 Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2
10/07/2004US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
10/07/2004US20040198717 4-(trifluoromethyl)-7,8,9,10-tetrahydrochromeno[7,6-b]azepin-2(6H)-one and derivatives;4-(trifluoromethyl)-1,6,7,8,9,10-hexahydro-2H-azepino[3,2-g]quinolin-2-one and derivatives; useful in the treating conditions caused by androgen deficiency such as bone disorders
10/07/2004US20040194236 Method of mass-colouring synthetic materials
10/07/2004DE10312969A1 Benzofuro-1,4-diazepin-2-on-Derivate Benzofuro-1,4-diazepin-2-one derivatives
10/07/2004CA2520440A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
10/07/2004CA2519987A1 Benzofuro-1,4-diazepin-2-one derivatives
10/06/2004EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function
10/06/2004EP1463717A2 Process for the synthesis of amine ethers from secondary amino oxides and uses
10/06/2004EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists
10/06/2004EP1318837B1 Method of treating estrogen receptor positive carcinoma
10/06/2004EP1037892B1 Piperidine derivatives
10/06/2004CN1535274A Antidepressant (SSSRI) azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6, 9-dioxa-1,3-diazacyclopenta[A] naphthalene
10/06/2004CN1535272A Nitrogen-containing bicyclic heterocycles
10/06/2004CN1535151A Novel anti-infectives
10/06/2004CN1534036A Derivative of camptothecin kind analogue and its preparation method
10/06/2004CN1534026A Condensed quinazoline derirative used as tyrosine kinase inhibitor
10/05/2004US6800656 Tricyclic compounds and method of treating herpes virus
10/05/2004US6800653 Anticancer agents
10/05/2004US6800650 For therapy and prophylaxis of diabetes, particularly non-insulin dependent diabetes mellitus and impaired glucose tolerance.
10/05/2004US6800646 Sulfamato hydroxamic acid metalloprotease inhibitor
10/05/2004US6800641 For therapy of schizophrenia, schizoaffective disorder, bipolar disorder, parkinson's disease, l-dopa induced psychoses or dyskinesias, tourette's syndrome, hyperprolactinemia, or addiction to ethanol, nicotine, cocaine
10/05/2004US6800637 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
10/05/2004US6800625 For therapy of sexual dysfunction
10/05/2004CA2244698C Derivatives of camptothecin for use in treating cancer
10/05/2004CA2128956C Tricyclic diazepine vasopressin antagonists
09/2004
09/30/2004WO2004083214A1 7-imino derivatives of camptothecin having antitumor activity
09/30/2004WO2004083213A1 4,6-dihydrofuro[3,4-d]imidazole-6-one derivatives and their salts and process for the preparation of the same
09/30/2004WO2004083184A1 Receptor antagonist
09/30/2004WO2004083167A1 Sulfamide derivative and medicinal composition thereof
09/30/2004WO2004082698A1 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments
09/30/2004WO2004041209A3 Transcription factor modulating compounds and methods of use thereof
09/30/2004WO2003097806A3 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/30/2004WO2003022785A3 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
09/30/2004US20040192920 Condensing a suitable alcohol with a piperidone in the presence of polyphosphoric acid.
09/30/2004US20040192917 Comprises of drying, grinding the plant, subjecting it to hot defatting with a light petroleum fraction followed by hot extraction with a solvent under vacuum to obtain crude extracts of the plant material, then precipitating and
09/30/2004US20040192748 Heterocyclic compounds
09/30/2004US20040192728 Antiinflammatory agents; analgesics
09/30/2004US20040192714 Analogs and prodrugs of buprenorphine
09/30/2004US20040192710 Such as trans-4-amino-3,4-dihydro-2,2-dimethyl-6-cyano-2H-benzopyran; for use as antiarrhythmic agents
09/30/2004US20040192705 Radiolabeled neuropeptide y y5 receptor antagonists
09/30/2004US20040192653 P38 inhibitors and methods of use thereof
09/30/2004US20040191668 Novel dyes and use thereof in imaging members and methods
09/29/2004EP1461341A1 Process for preparing a heteroaromatic compound substituted with one or more ether groups
09/29/2004EP1189905B1 Substituted heterocycle fused gamma-carbolines
09/29/2004EP0901487B9 2,3,6 trisubstituted-4(3h)-quinazolinones
09/29/2004CN1532198A Quaternary chelidonine derivatives
09/29/2004CN1532197A Process for separating and preparing hig purity samguinarine and chelerythrine
09/29/2004CN1532195A Novel method for preparing olmesartan
09/29/2004CN1168730C Production technology of camptothecin
09/29/2004CN1168717C Novel intermediates for prepn. of antihisatminic piperidine derivatives
09/29/2004CN1168716C Optical active tetrahydrobenzindole derivatives
09/28/2004US6797715 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
09/28/2004US6797710 Cardiovascular disorders; serine protease inhibitor; administering by mouth; bioavailability
09/28/2004US6797708 Enzyme inhibitors such as 4-(2-(1-benzhydryl-2-(2-((benzyl-sulfonyl)amino)ethyl)-5-chloro-1h-indol-3 -yl)ethoxy) benzoic acid, used as analgesics or antiinflammatory agents
09/23/2004WO2004080976A1 Phthalazinone derivatives
09/23/2004WO2004080962A1 2,4,6-phenyl substituted cyclic ketoenols
09/23/2004WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same
09/23/2004WO2004039317A3 Analogs and prodrugs of buprenorphine
09/23/2004US20040186168 Such as spiroadamantane on one side and 4-substituted spiro-cyclohexyl on other side; structurally simple, nontoxic, easy synthesis, potent parasiticides
09/23/2004US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate
09/23/2004US20040186132 Steroid receptor modulator compounds and methods
09/23/2004US20040186123 such as 2[(Benzyloxy)methyl]-8-methyl-2,3-dihydro[1,4]dioxino[2,3-f]quinoline; serotonin receptor antagonists for treatment of depression, obsessive compulsive disorders, panic disorder, generalized anxiety disorder, social anxiety disorders, sexual dysfunction, and eating disorders
09/23/2004US20040186115 for treatment of proliferative, cardiac, neurodegenerative, and autoimmune disorders
09/23/2004US20040186107 Diazabicyclic central nervous system active agents
09/23/2004US20040186095 Harringtonine and homoharringtonine are cephalotaxane drugs; natural or synthetic products from plant extracts; pure crystals; treating leukemia, tumors, parasitic disease, or as immunosuppressant, antitumor agents
09/23/2004US20040185255 Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles
09/23/2004DE10311300A1 New 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols, useful as total or selective herbicides and pesticides, e.g. insecticides, acaricides and nematocides for plant protection
09/22/2004EP1459753A1 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
09/22/2004EP1458724A1 Total synthesis of galanthamine, analogues and derivatives thereof
09/22/2004EP1458723A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
09/22/2004EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
09/22/2004EP1458691A2 Benzodiazepine derivatives, preparation thereof and use thereof
09/22/2004EP1458393A1 Substituted diketopiperazines as oxytocin antagonists
09/22/2004EP1458392A2 Acridone inhibitors of impdh enzyme
09/22/2004EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase
09/22/2004EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/22/2004EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases
09/22/2004EP1192165B1 Substituted heterocycle fused gamma-carbolines
09/22/2004EP1189904B1 Substituted heterocycle fused gamma-carbolines
09/22/2004EP1165694B1 4,7-dichlororhodamine dyes useful as molecular probes
09/22/2004EP1100781B1 High affinity ligands for nociceptin receptor orl-1
09/22/2004EP1054869B1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
09/22/2004EP0966468B1 Crown ether-derivatised perylenes
09/22/2004EP0912908B1 Novel photochromic heterocyclic fused indenonaphthopyrans
09/22/2004CN1531724A Optical data carrier containing heterocyclic azy dye as light-absorbing compound in information layer
09/22/2004CN1167698C New N-triazolyl methyl piperazine derivative using as neurokinin receptor antagonistic agent
09/22/2004CN1167681C Condensed indoline derivatives and their use as 5HT, in particular 5HT2 receptor ligands
09/21/2004US6794516 Synthesis of clasto-lactacystin β-lactone and analogs thereof
09/21/2004US6794509 Compounds for fluorescence labeling
09/21/2004US6794395 Substituted indolinones, their manufacture and their use as medicaments
09/21/2004US6794392 Cell differentiation inducer
09/16/2004WO2004078875A2 Novel dyes and use thereof in imaging members and methods
09/16/2004WO2004078874A2 Novel dye complexes and use thereof in imaging members and methods
09/16/2004WO2004078851A1 Novel dyes and use thereof in thermal imaging members and methods
09/16/2004WO2004078758A1 Novel fused heterocycles and uses thereof
09/16/2004WO2004078750A1 Tetrahydropyran compounds as tachykinin antagonists
09/16/2004WO2004078731A1 Quinoline-carboxylic acids and the derivatives thereof, a focused library
09/16/2004WO2004078712A2 Isoquinoline derivatives and methods of use thereof